1. Home
  2. BTO vs BVS Comparison

BTO vs BVS Comparison

Compare BTO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Financial Opportunities Fund

BTO

John Hancock Financial Opportunities Fund

HOLD

Current Price

$40.54

Market Cap

733.0M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$11.54

Market Cap

783.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTO
BVS
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.0M
783.2M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
BTO
BVS
Price
$40.54
$11.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.00
AVG Volume (30 Days)
44.9K
701.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.04
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
N/A
$290.75
Revenue Growth
N/A
N/A
52 Week Low
$32.01
$5.81
52 Week High
$41.00
$12.53

Technical Indicators

Market Signals
Indicator
BTO
BVS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
BTO
BVS

About BTO John Hancock Financial Opportunities Fund

John Hancock Financial Opportunities Fund is a United States-based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. Under normal circumstances, the fund will invest at least 80% of its net assets in equity securities of U.S. and foreign financial services companies of any size. These companies may include, but are not limited to, banks, thrifts, finance and financial technology companies, brokerage and advisory firms, real estate-related firms, insurance companies, and financial holding companies.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: